Researcher
Guy Bormans
- Disciplines:Other chemical sciences, Chemical product design and formulation, Biomaterials engineering, Medical imaging and therapy, Medicinal products
Affiliations
- Radiopharmaceutical Research (Division)
Responsible
From1 Oct 2014 → Today - Radiopharmaceutical Research (Division)
Member
From1 Oct 1999 → Today
Projects
21 - 30 of 39
- A high-resolution and high-sensitivity hybrid small animal PET-CT system for combined molecular/functional and anatomical preclinical imaging in neurology, oncology and cardiology.From1 May 2016 → 30 Apr 2020Funding: FWO Medium Size Research Infrastructure
- Adapting targeted protein aggregation for detection.From1 Oct 2014 → 30 Sep 2018Funding: IOF - Industrial Research Fund
- Development of Pept-Ins for in vivo imaging.From1 Sep 2014 → 20 Dec 2018Funding: IWT personal funding - strategic basic research grants
- MIRIAD: Molecular Imaging Research Initiative for Application in Drug Development.From1 Jan 2014 → 31 Dec 2017Funding: IWT / VLAIO - TETRA fund, SBO (Strategic basic research)
- translational study of the modulation of fosfodiesterase type 10A expression by dopaminergic neurotransmission using molecular imagingFrom1 Jan 2013 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- Glutamate mGluR2 and mGluR5 receptors in addiction: an in vivo multimodal, translational imaging study of their role in deficient corticostriatal control and modulation of dopaminergic neurotransmission.From1 Jan 2013 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- Improvement of motion correction techniques for microPET and PET/CT brain imaging.From1 Oct 2012 → 30 Sep 2013Funding: BOF - Other initiatives
- PET imaging of the mGluR5 receptor in addiction: its role in deficient corticostriatal control and glutamatergic modulation of dopaminergic neurotransmissionFrom1 Oct 2012 → 19 Jun 2017Funding: BOF - Doctoral projects
- An optical imaging system for in vivo bioluminescent and fluorescent imaging in small laboratory animals.From26 Apr 2012 → 25 Oct 2018Funding: Hercules - Small and Medium size research infrastructure
- Development and evaluation of PET ligands for the in vivo visualisation of phosphodiesterase type 5 (PDE5).From1 Jan 2012 → 31 Dec 2015Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 286
- Highlight selection of radiochemistry and radiopharmacy developments by editorial board(2023)
Authors: Guy Bormans
- Synthesis, Structure-Activity Relationships, Radiofluorination, and Biological Evaluation of [18F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET(2023)
Authors: Guy Bormans
Pages: 13991 - 14010 - Preclinical Evaluation of Novel PET Probes for Dementia(2023)
Authors: Romy Cools, Kobe Kerkhofs, Renan Leitao, Guy Bormans
Pages: 599 - 629 - In vivo performance of different 18F-labelled cannabinoid receptor 2 radioligands(2023)
Authors: Guy Bormans
Pages: S255 - S255 - Impact on clinical management when using [18F]AlFNOTA-octreotide instead of [68Ga]Ga-DOTA-SSA PET/CT in neuroendocrine tumor patients: preliminary results(2023)
Authors: Jeroen Dekervel, Frederik Cleeren, Michel Koole, Guy Bormans, Chris Verslype, Christophe Deroose
Pages: S508 - S508 - Radiopharmaceuticals for Cancer Imaging and Therapy(2023)
Authors: Guy Bormans, Frederik Cleeren
- Reverse engineering synthetic antiviral amyloids (vol 11, 2832, 2020)(2023)
Authors: Emiel Michiels, Rodrigo Gallardo, Laleh Khodaparast, Ladan Khodaparast, Rob van der Kant, Bert Houben, Nikolaos Louros, Suzanne Kaptein, Guy Bormans, Johan Neyts, et al.
- Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients(2023)
Authors: Frederik Cleeren, Jeroen Dekervel, Michel Koole, Guy Bormans, Annouschka Laenen, Paul Clement, Kristiaan Nackaerts, Chris Verslype, Koen Van Laere, Christophe Deroose
- 18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/ NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study(2023)
Authors: Elin Pauwels, Frederik Cleeren, Michel Koole, Jeroen Dekervel, Annouschka Laenen, Paul Clement, Chris Verslype, Guy Bormans, Christophe Deroose
Pages: 632 - 638 - Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist(2023)
Authors: Stephen Ahenkorah, Christopher Cawthorne, Christophe Deroose, Thomas Cardinaels, Guy Bormans, Frederik Cleeren
Patents
1 - 4 of 4